Level 2

PureTech sells shares in Karuna affiliate for $200m

By Frank Prenesti

Date: Thursday 23 Jan 2020

(Sharecast News) - Clinical stage biotech company PureTech Health said it had sold 2.1m shares of its affiliate Karuna Therapeutics for $200m.
PureTech Health said it intended to use the cash to fund operations and advance its clinical stage, wholly-owned pipeline.

The company on Thursday said it would still hold a 20.4% stake in Karuna's and a right to royalty payments on net sales of any commercialised product covered by a license granted by PureTech to Karuna.


Email this article to a friend

or share it with one of these popular networks:

Top of Page